共 50 条
- [1] Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD):: Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL).BLOOD, 2002, 100 (11) : 467A - 467AChoquet, SHerbrecht, RSocié, GStoppa, AMVandenberghe, PFeremens, WFischer, AMorschauser, FSalles, GVilmer, EGarnier, JLJaccard, ALamy, TLang, PLebranchu, YOffner, FOksenhendler, EImadalou, KFafi, SMoreau, ALeblond, VMilpied, N
- [2] Long term efficacy of rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Update of the multicenter, open label, phase II trial (M39037 trial).BLOOD, 2006, 108 (11) : 782A - 783AChoquet, SylvainHerbrecht, RaoulStoppa, Anne-MarieVandenberghe, PeterFeremans, WalterMorschhauser, FranckSalles, Gilles AndreJaccard, AmaudLamy, ThierryLebranchu, YvesOffner, PhilippeOksenhendler, EricRaphael, MartineLeblond, VeroniqueMilpied, Noel-Jean
- [3] Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 studyBLOOD, 2006, 107 (08) : 3053 - 3057Choquet, SLeblond, VHerbrecht, RSocié, GStoppa, AMVandenberghe, PFischer, AMorschhauser, FSalles, GFeremans, WVilmer, EPeraldi, MNLang, PLebranchu, YOksenhendler, EGarnier, JLLamy, TJaccard, AFerrant, AOffner, FHermine, OMoreau, AFafi-Kremer, SMorand, PChatenoud, LBerriot-Varoqueaux, NBergougnoux, LMilpied, N
- [4] Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative diseaseHAEMATOLOGICA, 2007, 92 (11) : 1489 - 1494Gonzalez-Barca, EvaDomingo-Domenech, EvaJavier Capote, FranciscoGomez-Codina, JoseSalar, AntonioBailen, AliciaRibera, Jose-MariaLopez, AndresBriones, JavierMunoz, AndresEncuentra, MaiteFernandez de Sevilla, Alberto
- [5] Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 TrialBLOOD, 2011, 118 (21) : 401 - 402Trappe, RalfOertel, Stephan H. K.Leblond, VeroniqueMollee, PeterSender, MonicaReinke, PetraNeuhaus, RuthLehmkuhl, HansHorst, Heinz A.Salles, Gilles AndreMorschhauser, FranckJaccard, ArnaudLamy, ThierryLeithaeuser, MalteAnagnostopoulos, IoannisRaphael, MartineRiess, HannoChoquet, Sylvain
- [6] Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study.AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 317 - 317Trappe, RalfChoquet, SylvainOertel, StephanLeBlond, VeroniqueEkman, TorSender, MonicaMollee, PeterReinke, PetraLehmkuhl, HansHummel, ManfredJonas, SvenNeuhaus, RuthSalles, GillesMorschhauser, FranckJaccard, ArnaudAnagnostopoulos, IoannisRaphael, MartineRiess, Hanno
- [7] Modified Risk-Stratified Sequential Treatment in B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) after Solid Organ Transplantation (SOT): The Prospective Multicenter Phase II PTLD-2 TrialBLOOD, 2021, 138Zimmermann, HeinerKoenecke, ChristianDreyling, Martin H.Pott, ChristianeDuhrsen, UlrichHahn, DennisMeidenbauer, NorbertHauser, Ingeborg A.Rummel, Mathias J.Wolf, DominikHeuser, MichaelSchmidt, ChristianSchlattmann, PeterRitgen, MatthiasSiebert, ReinerOschlies, IlskeAnagnostopoulos, IoannisTrappe, Ralf Ulrich
- [8] Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trialLANCET ONCOLOGY, 2012, 13 (02): : 196 - 206Trappe, RalfOertel, StephanLeblond, VeroniqueMollee, PeterSender, MonicaReinke, PetraNeuhaus, RuthLehmkuhl, HansHorst, Heinz AugustSalles, GillesMorschhauser, FranckJaccard, ArnaudLamy, ThierryLeithaeuser, MalteZimmermann, HeinerAnagnostopoulos, IoannisRaphael, MartineRiess, HannoChoquet, Sylvain
- [9] A prospective, open label trial of B-cell depletion with Rituximab in refractory systemic vasculitis.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 755A - 755ASmith, KGCJayne, DRW
- [10] Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trialLEUKEMIA, 2022, 36 (10) : 2468 - 2478Zimmermann, HeinerKoenecke, ChristianDreyling, Martin H.Pott, ChristianeDuehrsen, UlrichHahn, DennisMeidenbauer, NorbertHauser, Ingeborg A.Rummel, Mathias J.Wolf, DominikHeuser, MichaelSchmidt, ChristianSchlattmann, PeterRitgen, MatthiasSiebert, ReinerOschlies, IlskeAnagnostopoulos, IoannisTrappe, Ralf U.